Stay Updated
Press Releases
Statement on CMS Medicare Advantage Policy Change
WASHINGTON, DC — In light of the news that CMS will empower Medicare Advantage plans to negotiate for Part B drugs by using step therapy, Patients For Affordable Drugs President and Founder David Mitchell issued the following statement: “I appreciate Secretary Azar’s work to curb rising drug prices. Today’s action to give Medicare Advantage plans […]
Press Releases
Patients For Affordable Drugs Announces Campaign to Name The Most Hated Pharma CEO
WASHINGTON, D.C. — Pharmaceutical corporations have been exploiting patients to rake in record profits, but a few companies and their CEOs stand out from the crowd in their demonstrations of greed. Patients for Affordable Drugs is turning to the American people to choose the worst of the worst. For one month, starting today, people will […]
Press Releases
NEW AD: Fix the Broken System; Let Medicare Negotiate Lower Drug Prices
WASHINGTON, DC — President Donald Trump, Senator Bernie Sanders, and Americans across the country all agree: the federal government should negotiate lower prices for prescription drugs. In support of that common-sense idea, Patients for Affordable Drugs released a new digital ad to push for policy changes that let Medicare negotiate for lower drug prices. Also today, […]
Press Releases
WASHINGTON, DC — Drug giant Merck’s pledge to cut prices for seven drugs and limit price hikes to no more than the rate of inflation was revealed to be little more than a PR stunt will do virtually nothing to alleviate the suffering of patients under the ever-increasing prices of Merck’s blockbuster drugs. “Merck gave […]
Press Releases
Don't be fooled by drug price hike pauses
WASHINGTON, DC — In response to the announcement that Novartis is temporarily postponing price increases for five months, Ben Wakana, Executive Director of Patients For Affordable Drugs, issued the following statement: “Let’s keep reality in focus: Drug companies don’t get credit for keeping prices high. Novartis and Pfizer temporarily postponed regularly scheduled price gouging — […]
Press Releases
Not enough: Pfizer roll backs on drug price hikes are not a significant drug pricing reform
WASHINGTON, DC — In response to the announcement that Pfizer rolled back July price hikes on dozens of prescription drugs after a presidential Tweet condemning the multinational drug corporation’s most recent price increases, David Mitchell, president and founder of Patients For Affordable Drugs, issued the following statement: “We’re glad to see that President Trump took […]
Press Releases
Patients For Affordable Drugs Delivers Petition Demanding Drug Giant Vertex Lower Its Prices
WASHINGTON, DC — Patients For Affordable Drugs delivered a 9,000-signature petition to Boston-based drugmaker Vertex that asked the company to lower the prices of its charity-funded cystic fibrosis drugs. The petition comes as ICER, a drug pricing watchdog, published an analysis on May 3 that said Vertex cystic fibrosis drugs are overpriced by at least […]
Press Releases
Patients For Affordable Drugs Sends U.S. Patients to United Nations
NEW YORK — Patients For Affordable Drugs will join academics, business leaders and representatives from 190 international organizations at a U.N General Assembly hearing today. P4AD Patient Advocates plan to ask attendees to consider drug prices when discussing prevention and control of non-communicable diseases. “A big barrier to the control and management of non-communicable diseases […]